SEC Form 4 · accession 0001179110-16-016899
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Officer — Chief Executive Officer · Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 4, 2016 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 4, 2016 | M | 5,416 | $3.19 | A | 175,031 | D | |
| Common StockF1,F3 | Jan 4, 2016 | S | 5,416 | $13.1738 | D | 169,615 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $3.19 | Jan 4, 2016 | M | 5,416 | D | Jun 8, 2007 | Jun 8, 2016 | Common Stock | 5,416 | 27,085 | D |
Explanation of responses
- F1This transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan executed by the reporting person on June 1, 2015.
- F2Exercisable as to 21,667 shares commencing on June 8, 2007, 21,667 shares commencing on June 8, 2008, and 21,666 shares commencing on June 8, 2009.
- F3Weighted average price of shares sold.